Greg C. Flaker

15.9k citations

79 papers · 10.5k indexed · 3 hit papers · h-index 35

Impact in

Cardiology and Cardiovascular Medicine top 0.1%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Acute Myocardial Infarction Research
- Blood Pressure and Hypertension Studies
Internal Medicine top 1%

Papers in ⓘ

Cardiology and Cardiovascular Medicine 72
- Cardiac Arrhythmias and Treatments 28
- Atrial Fibrillation Management and Outcomes 26
- Cardiac pacing and defibrillation studies 23
- Cardiac electrophysiology and arrhythmias 19
- Heart Failure Treatment and Management 12
- Cardiovascular Function and Risk Factors 12
- Antiplatelet Therapy and Cardiovascular Diseases 11
Internal Medicine 6

Co-authors: Marc A. Pfeffer (14 shared papers)Lemuel A. Moyé (9 shared papers)Gervasio A. Lamas (13 shared papers)Jean L. Rouleau (7 shared papers)Lofty L. Basta (2 shared papers)Edward M. Geltman (3 shared papers)John D. Rutherford (4 shared papers)Eugene Braunwald (3 shared papers)
Journals: Journal of the American College of Cardiology (15 papers)American Heart Journal (11 papers)Circulation (7 papers)The American Journal of Cardiology (6 papers)Pacing and Clinical Electrophysiology (4 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Greg C. Flaker

76 papers receiving 9.9k citations

Hit Papers

align trajectories log scale

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels 1998 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 Circulation
1997 Circulation
1992 New England Journal of Medicine

Peers

Countries citing papers authored by Greg C. Flaker

Since Specialization

Citations

This map shows the geographic impact of Greg C. Flaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg C. Flaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg C. Flaker more than expected).

Fields of papers citing papers by Greg C. Flaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg C. Flaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg C. Flaker. The network helps show where Greg C. Flaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Greg C. Flaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Greg C. Flaker Line = papers co-authored together Greg C. Flaker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction New England Journal of Medicine ·Marc A. Pfeffer, Eugene Braunwald, Lemuel A. Moyé, Lofty L. Basta, Edward J. Brown, T. Edward Cuddy, Barry R. Davis, Edward M. Geltman, Steven Goldman, Greg C. Flaker, M D Klein, Gervasio A. Lamas, Milton Packer, Jacques R. Rouleau, Jean L. Rouleau, John D. Rutherford, J Wertheimer, C. Hawkins Hit paper breakdown →	1992	4375
2	Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels Circulation ·Paul M. Ridker, Nader Rifai, Marc A. Pfeffer, Frank M. Sacks, Lemuel A. Moyé, Steven Goldman, Greg C. Flaker, Eugene Braunwald Hit paper breakdown →	1998	1091
3	Clinical Significance of Mitral Regurgitation After Acute Myocardial Infarction Circulation ·Gervasio A. Lamas, Gary F. Mitchell, Greg C. Flaker, Sidney C. Smith, Bernard J. Gersh, Lofty L. Basta, Lemuel A. Moyé, Eugene Braunwald, Marc A. Pfeffer Hit paper breakdown →	1997	486
4	Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation Journal of the American College of Cardiology ·Greg C. Flaker, Joseph L. Blackshear, Ruth McBride, Richard A. Kronmal, Jonathan L. Halperin, Robert G. Hart	1992	458
5	Sphygmomanometrically Determined Pulse Pressure Is a Powerful Independent Predictor of Recurrent Events After Myocardial Infarction in Patients With Impaired Left Ventricular Function Circulation ·Gary F. Mitchell, Lemuel A. Moyé, Eugene Braunwald, Jean‐Lucien Rouleau, Victoria Bernstein, Edward M. Geltman, Greg C. Flaker, Marc A. Pfeffer, for the SAVE Investigators	1997	430
6	Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction New England Journal of Medicine ·Evan Loh, Martin St. John Sutton, Chuan‐Chuan Wun, Jean L. Rouleau, Greg C. Flaker, Stephen S. Gottlieb, Gervasio A. Lamas, Lemuel A. Moyé, Samuel Z. Goldhaber, Marc A. Pfeffer	1997	413
7	Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial Fibrillation Stroke ·Brian F. Gage, Michael Boechler, Amy L. Doggette, Gary Fortune, Greg C. Flaker, Michael W. Rich, Martha J. Radford	2000	249
8	Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation ·John D. Rutherford, Marc A. Pfeffer, L A Moyé, Barry R. Davis, Greg C. Flaker, Peter R. Kowey, Gervasio A. Lamas, Hadar Miller, Milton Packer, Jean‐Lucien Rouleau	1994	248
9	Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study American Heart Journal ·Greg C. Flaker, Kathy Belew, Karen J. Beckman, Humberto Vidaillet, Jack Kron, Robert E. Safford, Mary Mickel, Patrick Barrell	2005	242
10	Predictors of late development of heart failure in stable survivors of myocardial infarction Journal of the American College of Cardiology ·Eldrin F. Lewis, Lemuel A. Moyé, Jean L. Rouleau, Frank M. Sacks, J. Malcolm O. Arnold, J. Wayne Warnica, Greg C. Flaker, Eugene Braunwald, Marc A. Pfeffer	2003	240
11	Effect of Infarct Artery Patency on Prognosis After Acute Myocardial Infarction Circulation ·Gervasio A. Lamas, Greg C. Flaker, Gary F. Mitchell, Sidney C. Smith, Bernard J. Gersh, Chuan‐Chuan Wun, Lemuel A. Moyé, Jean L. Rouleau, John D. Rutherford, Marc A. Pfeffer, Eugene Braunwald, for the Survival Ventricular Enlargement Investigators	1995	133
12	Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation The American Journal of Cardiology ·Greg C. Flaker, (unknown), Kristin A. Fletcher, Robert M. Rothbart, Jonathan L. Halperin, Robert G. Hart	1995	123
13	Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials American Heart Journal ·Greg C. Flaker, Michael J. Gruber, Stuart J. Connolly, Steven Goldman, Sandra Chaparro, Alec Vahanian, Matti Halinen, Jay Horrow, Jonathan L. Halperin	2006	123
14	Impact of Diabetes on Mortality in Patients With Myocardial Infarction and Left Ventricular Dysfunction Archives of Internal Medicine ·Alvaro M. Murcia, Charles H. Hennekens, Gervasio A. Lamas, Manuel F. Jiménez‐Navarro, Jean L. Rouleau, Greg C. Flaker, Steven Goldman, Hicham Skali, Eugene Braunwald, Marc A. Pfeffer	2004	116
15	Electrophysiologic testing in patients with unexplained syncope: Clinical and noninvasive predictors of outcome Journal of the American College of Cardiology ·Ryszard B. Król, Fred Morady, Greg C. Flaker, Lorenzo A. DiCarlo, Jeffrey M. Baerman, John E. Hewett, Michael de Buitleir	1987	105
16	Causes of higher in-hospital mortality in women than in men after acute myocardial infarction The American Journal of Cardiology ·J. Stephen Jenkins, Greg C. Flaker, Barbie Nolte, Leigh Ann Price, Don Morris, James Kurz, Gregory F. Petroski	1994	91
17	Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation Circulation Cardiovascular Quality and Outcomes ·Greg C. Flaker, Janice Pogue, Salim Yusuf, Marc A. Pfeffer, Samuel Z. Goldhaber, Christopher B. Granger, Inder S. Anand, Robert G. Hart, Stuart J. Connolly	2010	89
18	Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration Heart Rhythm ·Himanshu H. Shukla, Anne S. Hellkamp, Erskine A. James, Greg C. Flaker, Kerry L. Lee, Michael O. Sweeney, Gervasio A. Lamas	2005	86
19	High Defibrillation Thresholds in Transvenous Biphasic Implantable Defibrillators: Pacing and Clinical Electrophysiology ·Himanshu H. Shukla, Greg C. Flaker, Vinod Jayam, David Roberts	2003	81
20	Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure Journal of the American College of Cardiology ·Martin Alpert, Jack J. Curtis, John F. Sanfelippo, Greg C. Flaker, Joseph T. Walls, Vaskar Mukerji, Daniel Villarreal, S. K. Katti, Niall P. Madigan, Ryszard B. Król	1986	81

About Greg C. Flaker

Greg C. Flaker is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery, Radiology, Nuclear Medicine and Imaging and Complementary and alternative medicine, having authored 79 papers that have together received 10.5k indexed citations. Recurring topics across this work include Cardiac Arrhythmias and Treatments (28 papers), Atrial Fibrillation Management and Outcomes (26 papers), Cardiac pacing and defibrillation studies (23 papers), Cardiac electrophysiology and arrhythmias (19 papers), Heart Failure Treatment and Management (12 papers), Cardiovascular Function and Risk Factors (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Cardiac Imaging and Diagnostics (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (9.0k citations), Internal Medicine (513 citations), Endocrinology, Diabetes and Metabolism (1.0k citations), Surgery (2.5k citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Greg C. Flaker has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marc A. Pfeffer, Lemuel A. Moyé, Gervasio A. Lamas, Jean L. Rouleau, Lofty L. Basta, Edward M. Geltman, John D. Rutherford, Eugene Braunwald, Barry R. Davis and Milton Packer. Their work appears in journals such as Journal of the American College of Cardiology, American Heart Journal, Circulation, The American Journal of Cardiology and Pacing and Clinical Electrophysiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact